Lavipharm S.A. (ATH:LAVI)

Lavipharm Revenue

In the year 2025, Lavipharm had annual revenue of 62.58M EUR with 18.20% growth. Lavipharm had revenue of 20.97M in the quarter ending December 31, 2025, with 55.41% growth.

• Revenue: 62.58M
• Revenue Growth: +18.20%
• P/S Ratio: 3.83
• Revenue / Employee: 221.93K
• Employees: 282
• Market Cap: 239.54M

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2025	62.58M	9.64M	18.20%
Dec 31, 2024	52.95M	5.11M	10.68%
Dec 31, 2023	47.84M	8.78M	22.48%
Dec 31, 2022	39.06M	-667.00K	-1.68%
Dec 31, 2021	39.72M	2.09M	5.54%